Spatiotemporal Immunomodulation and Biphasic Osteo-Vascular Aligned Electrospun Membrane for Diabetic Periosteum Regeneration

Under diabetic conditions, blood glucose fluctuations and exacerbated immunopathological inflammatory environments pose significant challenges to periosteal regenerative repair strategies. Responsive immune regulation in damaged tissues is critical for the immune microenvironment, osteogenesis, and angiogenesis stabilization. Considering the high-glucose microenvironment of such acute injury sites, a functional glucose-responsive immunomodulation-assisted periosteal regeneration composite material-PLA(Polylactic Acid?/COLI(Collagen I?/Lipo(Liposome?-APY29 (PCLA)-is constructed. Aside from stimulating osteogenic differentiation, owing to the presence of surface self-assembled type I collagen in the scaffolds, PCLA can directly respond to focal area high-glucose microenvironments. The PCLA scaffolds trigger the release of APY29-loaded liposomes, shifting the macrophages toward the M2 phenotype, inhibiting the release of inflammatory cytokines, improving the bone immune microenvironment, and promoting osteogenic differentiation and angiogenesis. Bioinformatics analyses show that PCLA enhances bone repair by inhibiting the inflammatory signal pathway regulating the polarization direction and promoting osteogenic and angiogenic gene expression. In the calvarial periosteal defect model of diabetic rats, PCLA scaffolds induce M2 macrophage polarization and improve the inflammatory microenvironment, significantly accelerating periosteal repair. Overall, the PCLA scaffold material regulates immunity in fluctuating high-glucose inflammatory microenvironments, achieves relatively stable and favorable osteogenic microenvironments, and facilitates the effective design of functionalized biomaterials for bone regeneration therapy in patients with diabetes. Multifunctional PLA/COLI/Lipo-APY29 (PCLA) is prepared for diabetic rat cranial defects. Glucose-responsive 4-fluorophenyl boric acid (FPBA) moiety prior to encapsulation with APY29 endows the electrospun scaffolds with immunomodulation ability, and the self-assembled collagen enhances the osteogenic capacity. Therefore, the functionalized electrospun scaffolds can regulate the immune microenvironment at the defect site to enhance the degree of vascularized bone regeneration and promote periosteum healing.image

Automated summary

A composite material called PCLA has been developed to regulate immune response in high-glucose inflammatory environments and promote bone regeneration and angiogenesis, which is of great significance for the healing of bone wounds in diabetic patients.